BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced a proposed public offering of its common stock and, in lieu of common stock to certain investors, prefunded warrants to purchase shares of common stock. All securities in the offering will be offer ...

公司融资活动 - Hyperfine公司宣布开始进行承销公开发行，出售其A类普通股，或向特定投资者发行可购买A类普通股的预先资助认股权证以代替股票 [1] - 此次发行的所有证券将由Hyperfine公司出售，公司还计划授予承销商一项30天期权，可购买至多相当于发行证券总数15%的额外证券 [1] - 此次发行受市场及其他条件约束，无法保证发行是否能完成、何时完成以及实际规模或条款 [1] 发行相关安排 - Lake Street Capital Markets担任此次拟议发行的唯一账簿管理人 [2] - 证券发行依据公司之前向美国证券交易委员会提交并于2023年11月22日宣布生效的S-3表格货架注册声明进行 [3] - 证券发行仅通过构成注册声明一部分的招股说明书补充文件进行，初步招股说明书补充文件及相关基本招股书将在SEC网站提供 [3] 公司业务背景 - Hyperfine是一家开创性健康技术公司，其重新定义了脑成像，拥有Swoop®系统——首个经FDA批准、便携式、超低场强的脑部磁共振成像系统 [5] - 公司使命是通过变革性、可及性、临床相关的诊断成像来彻底改变全球患者护理 [5] - Swoop®系统由Hyperfine的科学家、工程师和物理学家在4Catalyzer技术孵化器中开发，旨在重新定义脑成像方法学及临床护理中的应用 [5]

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced the pricing of an underwritten public offering of 11,000,000 shares of its common stock at a public offering price of $12.00 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase up to an aggregate of 1,500,000 share ...

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that it has commenced an underwritten public offering of $150 million of shares of its common stock. All of the shares are being offered by EyePoint. In addition, EyePoint intends to grant the underwriters an option for a period of 30 days to purchase up ...

融资活动概述 - 公司宣布承销商已全额行使超额配售权，额外购买3,295,076股普通股 [1] - 行使超额配售权后，本次公开发行的总股数增至26,372,000股，每股发行价为6.50美元 [1][2] - 本次融资的总收益（在扣除承销折扣和发行费用前）约为1.714亿美元 [2] 融资规模与时间 - 本次公开发行最初规模为1亿美元，后扩大至约1.5亿美元，最终总融资额约为1.714亿美元 [2] - 包含超额配售权股份在内的本次发行预计于2025年10月14日完成，具体取决于惯例交割条件 [2] 资金用途 - 融资净收益将用于扩大和加速公司的勘探和钻探项目 [4] - 部分资金将用于一般公司运营及营运资金需求，包括预期偿还或回购并清偿公司现有债务 [4] 公司业务背景 - 公司是一家美国金矿和银矿企业，正在开发位于内华达州的Hycroft矿，该矿是全球最大的贵金属矿床之一 [7] - 公司目前正致力于完成技术研究，以将Hycroft矿从历史上的氧化物堆浸作业过渡到处理硫化矿的商业运营新阶段 [7] - 公司正在进行一项强有力的勘探钻探计划，以进一步扩大新发现的高品位主导银矿系统 [7]

New York, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of Public Offering (the “Offering”) of approximately $8 million for its client EPWK Holdings Ltd. (NASDAQ: EPWK) (the “Company”), a company that connects businesses with great talents through innovative and efficient cloud-sourcing platforms. The offering is comprised of 24,242,425 unit ...

公司融资活动 - 公司完成公开增发定价 发行1550万股普通股 每股价格为13.15美元 [1] - 承销商获得30天期权 可额外购买最多232.5万股公司普通股 [1] 资金用途 - 增发所筹资金将用于加速美国铀精炼与转化公司的开发 [1]

融资完成概要 - 公司成功完成此前宣布的公开发行，以每单位0.35加元的价格发行了65,780,000个单位，总收益约为23,023,000加元，并全额行使了超额配售权 [1] - 此次发行由BMO Capital Markets作为主承销商，Research Capital Corporation作为联合牵头代理，共同组成的承销团负责 [1] 融资单位结构 - 每个单位包含一股公司普通股和半份公司普通股认购权证 [2] - 每份完整权证赋予持有人在发行结束后的24个月内，以每股0.55加元的行权价购买一股普通股的权利 [2] - 若普通股收盘价连续20个交易日超过0.75加元，公司有权在发生后10日内通知持有人，将权证到期日加速至通知日期后30天 [2] 资金用途与承销佣金 - 承销团获得相当于发行总收益6.0%的现金佣金，金额为1,381,380加元 [3] - 发行所得净收益将用于Santa Ana项目的勘探和钻探，以及一般营运资金用途 [3] 主要投资者参与 - Jupiter Asset Management以每单位0.35加元的价格认购了42,857,142个单位，总投资额为1500万加元 [4] - Eric Sprott先生通过其全资拥有的公司2176423 Ontario Ltd，以每单位0.35加元的价格认购了14,285,716个单位，总投资额为500万加元 [4] 公司背景与项目 - 公司是一家勘探和开发商，专注于推进其位于哥伦比亚的旗舰项目Santa Ana高级银矿 [7] - 公司致力于通过战略性勘探计划扩大现有矿产资源，并专注于负责任的采矿实践和社区参与 [8]

HONG KONG, Oct. 02, 2025 (GLOBE NEWSWIRE) -- CCSC Technology International Holdings Limited (the “Company”) (Nasdaq: CCTG), a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products, including connectors, cables and wire harnesses, today announced the closing of its previously announced best-efforts public offering (the “Offering”) of (i) 11,766,627 Class A ordinary shares (the “Class A Ordinary Shares”) and (ii) 23,533,254 warrants to purchase 23,533,254 Class A ...

HONG KONG, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CCSC Technology International Holdings Limited (the “Company”) (Nasdaq: CCTG), a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products, including connectors, cables and wire harnesses, today announced the pricing of a best-efforts public offering (the “Offering”) of (i) 11,766,627 Class A ordinary shares (the “Class A Ordinary Shares”) and (ii) 23,533,254 warrants to purchase 23,533,254 Class A Ordinary Shares (the “W ...